Clinical Trials for Inflammatory bowel disease

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Inflammatory bowel disease is grouped into the following categories:-

View by trial name

View by drugs used in Inflammatory bowel disease clinical trials

Clinical Trials by trial name

The format for each of the following is:

The name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Inflammatory bowel disease:

Immune Regulation in Ulcerative Colitis or Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus - This study is currently recruiting patients (Current: 23 Nov 2006) - ganciclovir
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-Severe Ulcerative Colitis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Daclizumab
The Influence of 5Aminosalicylates on Thiopurine Metabolite Levels - This study is currently recruiting patients (Current: 23 Nov 2006) - 5-aminosalicylate (Pentasa, Ferring)
NICE: Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study - This study is currently recruiting patients (Current: 23 Nov 2006) - Nolpitantium besylate
Infectious Agents in Pediatric Crohn's - This study is currently recruiting patients (Current: 23 Nov 2006)
Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease - This study is no longer recruiting patients (Current: 23 Nov 2006)
Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas - This study is currently recruiting patients (Current: 23 Nov 2006) - AST-120
Genetic Studies of Inflammatory Bowel Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Telomere Repair Gene Mutation in Inflammatory Bowel Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Infliximab to Treat Crohn's-Like Inflammatory Bowel Disease in Chronic Granulomatous Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab
Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Dexamethasone,Methylprednisolone
Collection of Specimens for Study of Inflammatory Bowel Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD) - This study is currently recruiting patients (Current: 23 Nov 2006)
Transition Study of IBD Patients From Pediatric Gastroenterologist to Adult Gastroenterologist - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease - This study has been completed (Current: 23 Nov 2006) - Methotrexate
Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis - This study has been terminated (Current: 23 Nov 2006) - rhIL-11
Study Evaluating rhIL-11 in Active Crohns Disease - This study has been completed (Current: 23 Nov 2006) - Recombinant Human Interleukin-11 (rhIL-11)
Clotrimazole Enemas for Pouchitis in Children and Adults - This study is currently recruiting patients (Current: 23 Nov 2006) - Clotrimazole,Retention Enema
A Trial of Rosiglitazone for Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - rosiglitazone (Avandia)
A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease. - This study is currently recruiting patients (Current: 23 Nov 2006) - Probiotic - VSL#3
NPD Testing: Evaluation of CFTR Function in Children With PSC - This study is currently recruiting patients (Current: 23 Nov 2006)
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Dietary Treatment of Crohn's Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Diet and prebiotic supplement ( fructooligosaccharide)
Extension Study to Evaluate Safety, Efficacy, and Corticosteroid Sparing Effect of Certolizumab in Patients With Crohns Disease. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - certolizumab pegol
CNI-1493 for Treatment of Moderate to Severe Crohns Disease - This study has been terminated (Current: 23 Nov 2006) - CNI-1493
CP-461 for the Treatment of Crohns Disease - This study has been completed (Current: 23 Nov 2006) - CP-461
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohns Disease - This study has been completed (Current: 23 Nov 2006) - Antegren(TM) (natalizumab)
Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - azathioprine
COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial) - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab - Methotrexate Combination Therapy
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission - This study is currently recruiting patients (Current: 23 Nov 2006) - Mesalamine pellets
A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Subjects With Moderately to SeverelyActive Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - infliximab (REMICADE)
Corticosteroid Sparing Effect of Certolizumab - This study is currently recruiting patients (Current: 23 Nov 2006) - certolizumab pegol
A Double Blind Study for the Treatment of Acute Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Mesalamine
An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Dehydroepiandrosterone [DHEA]
Imuran Dosing in Crohn's Disease Study - This study is currently recruiting patients (Current: 23 Nov 2006) - IMURAN (azathioprine)
Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - aminosalicylic acid
Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - aminosalicylic acid
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - monoclonal antibody cA2
Monoclonal Antibody Treatment of Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - J695
Study of Immune Ablation With High-Dose Cyclophosphamide and Anti-Thymocyte Globulin Followed By Autologous Peripheral Blood Stem Cell Rescue in Patients With Severe Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Anti-thymocyte globulin,Cyclophosphamide,filgrastim
G-CSF to Treat Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - G-CSF
Research Study in Patients With Severe Ulcerative Colitis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Visilizumab
Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - natalizumab
Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - natalizumab
Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - deligoparin
Multicenter Trial For Patients With Acute Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - etiprednol dicloacetate
A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - Infliximab
Alicaforsen (ISIS 2302) in Patients With Active Crohns Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Alicaforsen
Alicaforsen (ISIS 2302) in Patients With Active Crohns Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Alicaforsen
Interferon-Beta Treatment of Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Interferon-beta
Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohns Disease - This study has been completed (Current: 23 Nov 2006) - Natalizumab
Remission in Subjects With Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adalimumab (D2E7)
A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - Adalimumab (D2E7)
Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohns Disease - This study has been completed (Current: 23 Nov 2006) - Natalizumab
Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - UVADEX and UVAR XTS Photopheresis System
Quality of Life in Pediatric Inflammatory Bowel Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Alicaforsen
ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Alicaforsen
FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - OPC-6535 Tablets (drug)
FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - OPC-6535 Tablets (drug)
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - ALX-0600
A Humanized Anti-Interferon- Monoclonal Antibody (HuZAF) for Moderate to Severe Crohns Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-Interferon-gamma monoclonal antibody
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - Asacol (mesalamine)
An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - Epanova™ (Omega-3 Free Fatty Acids)
Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohns Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Adalimumab
STA-5326 in Crohn's Disease Patients - This study has been completed (Current: 23 Nov 2006) - STA-5326
CORE: A Study of OPC-6535 With Asacol in Maintaining Ulcerative Colitis (UC) Remission - This study is currently recruiting patients (Current: 23 Nov 2006) - OPC-6535,Asacol®
SONIC Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab,Azathioprine
A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - Infliximab
Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease - This study has been terminated (Current: 23 Nov 2006) - 683699
Study for the Treatment of Ulcerative Colitis With Adacolumn - This study is no longer recruiting patients (Current: 23 Nov 2006)
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohns Disease - This study has been completed (Current: 23 Nov 2006) - CCX282-B
Extracorporeal Photopheresis Therapy to Treat Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Uvadex
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - Adalimumab
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Somatropin, E-coli Derived
VSL#3 Versus Placebo in Maintenance of Remission in Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - VSL#3
Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Calcitonin nasal spray (salmon)
A Trial of Wellbutrin for Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - Wellbutrin (bupropion)
Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Nitazoxanide
Vitamin D Treatment for Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Vitamin D
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - STA-5326 mesylate
Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients - This study has been completed (Current: 23 Nov 2006)
FishGastro Study: Fish Consumption and Gastro-Intestinal Health - This study is currently recruiting patients (Current: 23 Nov 2006)
Wireless Capsule Endoscopy in Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006)
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - mesalazine
Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. - This study is no longer recruiting patients (Current: 23 Nov 2006) - SPD476 (mesalazine)
Study to Test the Effect of CDP870 in the Treatment of Crohns Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870). - This study is no longer recruiting patients (Current: 23 Nov 2006) - Certolizumab Pegol (CDP870)
A Study to Test the Effect of CDP870 in the Treatment of Crohns Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo) - This study is no longer recruiting patients (Current: 23 Nov 2006) - Certolizumab Pegol (CDP870)
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Iron supplement 300-600 mg/day,Vitamin E 800IU
A Phase III A Study to Assess the Safety of CDP870 for Up to 30 Months Exposure - This study is no longer recruiting patients (Current: 23 Nov 2006) - Certolizumab Pegol (CDP870)
Study to Assess the Safety of CDP870 for Up to 30 Months Following Reintroduction of Treatment - This study is no longer recruiting patients (Current: 23 Nov 2006) - Certolizumab Pegol (CDP870)
Study for the Treatment of Crohns Disease With Adacolumn - This study is currently recruiting patients (Current: 23 Nov 2006)
Safety of Celecoxib in Patients With Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Celecoxib
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Immune Ablation and Stem Cell Support for Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Budesonide Treatment for Lymphocytic Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Budesonide
Open-Label of LEUKINE in Active Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Sargramostim
Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohns Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Sargramostim
Asacol Dosing Study for Active Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Asacol
Long-Term Open-Label Safety and Efficacy Study of Adalimumab in Subjects With Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - adalimumab
Safety and Efficacy Study in Patients With Crohns Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohns Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Sargramostim
Safety and Efficacy Study in the Treatment of Pediatric Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Sargramostim
Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohns Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Sargramostim
Open-Label Trial of LEUKINE in Active Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Sargramostim
Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohns Disease Who Have Previously Responded to Treatment With Sargramostim - This study is no longer recruiting patients (Current: 23 Nov 2006) - Sargramostim
A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab or placebo
A Study of the Safety and Efficacy of Inflixiamb (Remicade) in Pediatric Patients With Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab
A Long Term Safety Study of Infliximab (Remicade) - This study is no longer recruiting patients (Current: 23 Nov 2006)
A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab or placebo
Cerebral Resonance Magnetic Imaging During Rectal Distention - This study is currently recruiting patients (Current: 23 Nov 2006)
Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) - This study is currently recruiting patients (Current: 23 Nov 2006)
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Methoxsalen
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists - This study is currently recruiting patients (Current: 23 Nov 2006) - TNF-alpha antagonists
Multicentre, Controlled, Randomised, Open, Cross-Over Study Comparing the Acceptability of Pentasa Sachets Versus Pentasa Tbl. 500 Mg in Children With Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Crohn's Disease
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - STA-5326 mesylate
The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Crohn's Disease
Study Evaluating ERB-041 in Active Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - ERB-041
The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - STA-5326
Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment. - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab
A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. - This study is currently recruiting patients (Current: 23 Nov 2006) - Asacol (mesalazine)
Study of Antibiotics in the Treatment of Colonic Crohn's Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Metronidazole and Ciprofloxacin
Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Retarded Release Phosphatidylcholine (rPC)
Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis - This study is currently recruiting patients (Current: 23 Nov 2006) - retarded release phosphatidylcholine
Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - retarded release phosphatidylcholine
Rituximab in Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Rituximab
A Long Term Safety Study of Infliximab (Remicade) - This study is no longer recruiting patients (Current: 23 Nov 2006)
A Study of the Safety and Efficacy of C01275 in Subjects With Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - C01275
Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis - This study is currently recruiting patients (Current: 23 Nov 2006) - MODULEN IBD (R) (specific Enteral Nutrition),prednisolon
Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Visilizumab
Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Visilizumab
Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - Visilizumab
Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - lactobacilus acidophilus & bifidobacterium animalis/lactis
Clarithromycin in Active Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Clarithromycin
A Trial to Evaluate the Safety and Efficacy of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium 3.3G BID Versus Placebo in Mildly to Moderately Active Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - 5 ASA, enemas, suppositories, corticosteroids
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - anti-TNF chimeric monoclonal antibody (cA2)
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease - This study is no longer recruiting patients (Current: 23 Nov 2006) - cA2
Crohns Disease Stem Cell Transplantation - This study is currently recruiting patients (Current: 23 Nov 2006)
Chromoendoscopy for Ulcerative Colitis Surveillance - This study is currently recruiting patients (Current: 23 Nov 2006)
Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - beta carotene from Dunaliella algae
Hematopoietic Stem Cell Support in Patients With Severe Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study - This study is currently recruiting patients (Current: 23 Nov 2006) - Visilizumab (Nuvion®; HuM291)
A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Visilizumab (Nuvion®; HuM291)
Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease - This study has been completed (Current: 23 Nov 2006) - Natalizumab
Effects of Growth Hormone in Chronically Ill Children - This study is no longer recruiting patients (Current: 23 Nov 2006) - Growth Hormone
Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Delayed Release 6MP or Calcitriol vs. Purinethol
Glucocorticoid-Induced Osteopenia in Children - This study is currently recruiting patients (Current: 23 Nov 2006)
Early Alimentation Following Colorectal Surgery - This study is currently recruiting patients (Current: 23 Nov 2006)
Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol (CDP870)
NBI With Magnification for Dysplasia Detection in Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006)
Prochymal Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-Severe Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Prochymal™ adult human mesenchymal stem cells
Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Sargramostim
Phase I, Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - MDX-1100 (anti-CXCL10 human monoclonal antibody)
Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Sargramostim
Therapeutic Study of ONO-4819CD for Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Rivenprost (drug)
ASTIC Autologous Stem Cell Transplantation for Crohns Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
Mucosal Healing Study - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol
Study of COLAL-PRED in the Treatment of Moderate Acute Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - COLAL-PRED®,Prednisolone
Oral Budesonide vs. Oral Mesalazine in Active CD - This study is currently recruiting patients (Current: 23 Nov 2006) - budesonide
Safety and Efficacy of Interferon Beta-1a Rebif for Treating Patients With Acute Symptoms of Ulcerative Colitis - This study has been completed (Current: 23 Nov 2006) - Interferon beta-1a
Safety and Efficacy of Treatment With Interferon Beta-1a Rebif in Patients With Crohns Disease - This study has been terminated (Current: 23 Nov 2006) - Interferon beta-1a
Synbiotic Treatment in Crohn's Disease Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Synbiotic (Synergy I / B.longum)
A Multinational, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - CCX282-B
Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) - This study is currently recruiting patients (Current: 23 Nov 2006) - Visilizumab (Nuvion®; HuM291)
Certolizumab Pegol for Treatment of Adult Greek Population With Moderate to Severe Crohns Disease, Who Failed on Infliximab - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Certolizumab pegol
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 - This study is no longer recruiting patients (Current: 23 Nov 2006) - Teduglutide
Certolizumab in Crohn's Disease Patient With Loss of Response or Intolerance to Infliximab - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol
Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Rosiglitazone
A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Tetomilast
A Dose-Finding Study of OPC-6535 in Patients With Active Crohns Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Tetomilast
Maintenance Study Including Re-Induction Therapy for Those Patients Who Did Not Demonstrate a Clinical Effect in Study CDP870-037 - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol (CDP870)
Maintenance Study of CDP870 in Crohn's Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol (CDP870)
Open Label Long Term Follow up Study With Certolizumab Pegol for Patients Completing C87042 - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Certolizumab pegol
A Multi-Center, Open-Label Treatment Protocol of the Human Anti-TNF Monoclonal Antibody Adalimumab in Patients With Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE) - This study is currently recruiting patients (Current: 23 Nov 2006) - adalimumab
Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Asacol (mesalamine)
FK506 P-III Placebo-Controlled Double-Blind Study in Moderate to Severe Refractory Ulcerative Colitis Patients - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - tacrolimus
Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon - This study is currently recruiting patients (Current: 23 Nov 2006) - adalimumab
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Asacol
Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia - This study has been completed (Current: 23 Nov 2006)
Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohns Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - C326, IL-6 Inhibitory Avimer protein
Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Certolizumab pegol
Antibiotics for the Treatment of Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Cefuroxime,Ciprofloxacin,Clarithromycin,Cotrimoxazole,Coamoxiclav,metronidazole,neomycin,rifaximin,Vancomycin,Doxycycline
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis - This study is currently recruiting patients (Current: 23 Nov 2006) - Visilizumab (Nuvion®; HuM291)
Open Label Long Term Clinical Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohns Disease Patients Having Completed C87055 Study. - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Certolizumab pegol
Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
CESA 5.10 (Efficacy and Safety of Adacolumn Granulocytes, Monocytes/Macrophage Apheresis Device, 5 Versus 10 Treatments, in Patients With Active Ulcerative Colitis) - This study is currently recruiting patients (Current: 23 Nov 2006)
VSL#3 Treatment in Children With Crohn's Disease - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - VSL#3
Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohns Disease. - This study has been completed (Current: 23 Nov 2006)
Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. - This study has been completed (Current: 23 Nov 2006)
Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's Indexes - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
Use of FDG PET/CT to Evaluate Crohn Disease - This study is currently recruiting patients (Current: 23 Nov 2006)
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Adalimumab
Methods of Improvement Adherence With Therapy in Ulcerative Colitis. - This study is not yet open for patient recruitment (Current: 23 Nov 2006)

Drugs used in Clinical Trials for Inflammatory bowel disease

The format for each of the following is:

The drug,
followed by the name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Inflammatory bowel disease: